Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2004 Jan;42(1):458–460. doi: 10.1128/JCM.42.1.458-460.2004

Clinical and Environmental Distributions of Legionella Strains in France Are Different

Anne Doleans 1, Helena Aurell 2, Monique Reyrolle 2, Gerard Lina 2, Jean Freney 1, Francois Vandenesch 2, Jerome Etienne 2, Sophie Jarraud 2,*
PMCID: PMC321724  PMID: 14715805

Abstract

In France, the clinical distribution of Legionella species and serogroups does not correspond to their environmental distribution. Legionella pneumophila serogroup 1 is more prevalent among clinical isolates (95.4%) than in the environment (28.2%), whereas L. anisa is more frequent in the environment (13.8%) than in the clinical setting (0.8%).


Legionella infection occurs mainly by inhalation of aerosols generated from water sources such as distribution systems and cooling towers (13). The species Legionella pneumophila accounts for about 90% of the cases of legionellosis, and about 85% are due to serogroup 1 (5, 16). Other Legionella species are rarely pathogenic in humans, the most common being L. longbeachae (3.9%) and L. bozemanii (2.4%), except for in Australia and New Zealand, where L. longbeachae is responsible for 30% of the cases of Legionnaires' disease (16). In contrast, the distribution of Legionella species and serogroups in the environment is poorly known; most environmental studies have involved limited numbers of samples (4, 11, 14, 17) and/or only identified the species L. pneumophila (7, 9, 11, 14, 15).

To determine whether the clinical distribution of Legionella species and serogroups reflects their environmental predominance, we studied three collections of clinical and environmental isolates obtained from the French national Legionella surveillance network.

All of the Legionella strains (n = 259) isolated from patients with Legionnaires' disease in France between July 2001 and December 2002 in 57 French departments were sent to the national Legionella reference center (NRCL) as part of the epidemiological surveillance system. Fifty-eight percent were community acquired, 16% were hospital acquired, and 26% were of undetermined origin. The species and serogroup distribution was comparable to that reported elsewhere: L. pneumophila was responsible for more than 90% of the cases, and L. pneumophila serogroup 1 accounted for the majority of these (Table 1) (5, 16). In contrast to the collection of clinical strains, the NRCL panel of environmental strains is not exhaustive and is not systematically isolated from the environment for clinical cases. To minimize the sampling bias, we studied two different collections of environmental isolates: (i) 2,747 strains isolated by standard methods in 66 French departments between July 2001 and December 2002 and sent to the NRCL for identification and (ii) 381 strains isolated by the NRCL from 554 water samples originating from four French departments between January 2001 and July 2002. The water samples were collected from taps, showers, water valves, boilers, cooling towers, fountains, thermal waters, swimming pools, medical sprays, and air conditioners. Most (87.3%) came from hospital water systems, and the remainder came from private buildings, hotels, airports, spas, and swimming pools (12.7%). Legionellae were isolated in accordance with the ISO 11731 standard procedure (6) and identified to the species and serogroup levels (10 colonies per sample) by direct immunofluorescence with polyclonal rabbit sera raised by the NRCL. Legionella isolates showing cross-reactions with rabbit sera were identified to the species level by random amplified polymorphic DNA PCR (8) or by sequencing of the mip gene (12). The proportion of each species and serogroup was compared between the two environmental panels by using a two-tailed χ2 test with a significance level of 5%. The distribution was similar in the two panels (Table 1), and we thus considered the two populations to be representative of environmental Legionella colonization in France. The nationwide and Lyon panels comprised mainly L. pneumophila (75.5 and 75.6%, respectively). L. pneumophila serogroup 1 represented 28.2 and 29.1% of the isolates, respectively, and non-pneumophila species accounted for 24.5 and 24.4% of the isolates, respectively (Table 1).

TABLE 1.

Comparative Legionella species and serogroup distribution in clinical and environmental isolates

Legionella species or serogroup No. (%) of clinical isolates χ2 testaP value No. (%) of environmental isolates
Identified by NRCL From water samples
L. pneumophila serogroups 256 (98.8) NC 2,073 (75.5) 288 (75.6)
    1 247 (95.4) <0.05 776 (28.2) 111 (29.1)
    2 1 (0.4) NS 64 (2.3) 6 (1.6)
    3 3 (1.2) NS 296 (10.8) 64 (16.8)
    5 0 (0) NS 38 (1.4) 18 (4.7)
    6 2 (0.8) NS 305 (11.1) 15 (3.9)
    8 0 (0) NS 79 (2.9) 0 (0)
    Otherb 3 (1.2) NC 515 (18.7) 74 (19.4)
L. anisa 2 (0.8) <0.05 378 (13.8) 61 (16.0)
L. taurinensis 0 (0) NS 78 (2.8) 13 (3.4)
L. erythra 0 (0) NS 42 (1.5) 6 (1.6)
L. rubrilucens 0 (0) NS 32 (1.2) 0 (0)
L. tucsonensis 1 (0.4) NC 0 (0) 0 (0)
Other Legionella species 0 (0) NC 144 (5.2)c 13 (3.4)d
Total non-pneumophila legionellae 3 (1.2) NC 674 (24.5) 93 (24.4)
    Total 259 (100) NC 2,747 (100) 381 (100)
a

χ2 test comparing the distributions of species and serogroups between clinical and environmental isolates identified by the NRCL. Significantly different when P < 0.05, NS, not significant; NC, not calculated.

b

Other L. pneumophila serogroups and strains cross-reacting with several serogroups in an immunofluorescence assay.

c

Other Legionella species (no.): L. bozemanii (1), L. brunensis (1), L. dumofii (16), L. feeleii (9), L. geestiana (2), L. gormanii (14), L. jordanis (4), L. londiniensis (13), L. maceachernii (8), L. micdadei (16), L. moravica (3), L. oakridgensis (9), L. quinlivanii (4), L. sainthelensi (3), and L. spiritensis (1).

d

Other Legionella species (no.): L. dumofii (1), L. feeleii (1), L. londiniensis (1), and L. moravica (4).

To determine whether the environmental situation reflected the clinical distribution, the species and serogroup distributions were compared between the 2,747 environmental isolates and the 259 clinical isolates. The distributions of most species and serogroups differed significantly. In particular, L. pneumophila serogroup 1 accounted for 95.4% of the clinical isolates but only 28.2% of the environmental isolates (Table 1), while L. pneumophila serogroup 3 accounted for only 1.2% of the human isolates compared to 10.8% of the environmental isolates. Non-pneumophila legionellae accounted for only 1.2% of the clinical cases but 24.5% of the environmental isolates. L. anisa, the most frequent non-pneumophila species in the environment (13.8%), accounted for only 0.8% of the clinical isolates.

Only 15.8% of the clinical isolates were from confirmed nosocomial cases, whereas 87.3% of the samples collected in the Lyon area were from hospitals; the origin of the 2,747 isolates was not known. However, the distribution of species and serogroups did not change when only nosocomial isolates were considered; for example, L. pneumophila serogroup 1 accounted for 97.6% of the clinical isolates and 27.4% of the environmental isolates.

We then examined the level of Legionella colonization of hospital water systems by studying the 554 water samples predominantly collected from hospitals (87.3%). The 286 positive water samples (51.6%) contained between 102 and 107 Legionella CFU/liter, and 138 samples (48.3% of the positive samples) contained ≥103 CFU/liter. Despite this frequent contamination of hospital water systems in France, hospital-acquired legionellosis remains relatively infrequent, with about 100 cases annually (15% of all of the cases in France) (3).

The high frequency of L. pneumophila serogroup 1 isolation from clinical samples, as previously observed (5, 16), is not therefore linked to environmental predominance but may be due to higher infectivity or more efficient intracellular growth (1, 2). The low prevalence of non-pneumophila species among clinical isolates relative to their environmental abundance suggests that these species are less pathogenic than L. pneumophila, in keeping with the observation that most confirmed infections involving non-pneumophila species occur in immunosuppressed patients (10).

In conclusion, the clinical prevalence of Legionella species and serogroups appears to be explained by differences in pathogenicity rather than environmental predominance.

Acknowledgments

We thank David Young for editing the manuscript and Philippe Vanhems for useful suggestions.

REFERENCES

  • 1.Alli, O. A., S. Zink, N. K. Von Lackum, and Y. Abu-Kwaik. 2003. Comparative assessment of virulence traits in Legionella spp. Microbiology 149:631-641. [DOI] [PubMed] [Google Scholar]
  • 2.Brassinga, A. K., M. F. Hiltz, G. R. Sisson, M. G. Morash, N. Hill, E. Garduno, P. H. Edelstein, R. A. Garduno, and P. S. Hoffman. 2003. A 65-kilobase pathogenicity island is unique to Philadelphia-1 strains of Legionella pneumophila. J. Bacteriol. 185:4630-4637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Campese, C., and B. Decludt. 2003. Les légionelloses déclarées en France en 2002. Bull. Epidemiol. Hebd. 32:153-155. [Google Scholar]
  • 4.Codony, F., J. Alvarez, J. M. Oliva, B. Ciurana, M. Company, N. Camps, J. Torres, S. Minguell, N. Jove, E. Cirera, T. Admetlla, R. Abos, A. Escofet, A. Pedrol, R. Grau, I. Badosa, and G. Vila. 2002. Factors promoting colonization by legionellae in residential water distribution systems: an environmental case-control survey. Eur. J. Clin. Microbiol. Infect. Dis. 21:717-721. [DOI] [PubMed] [Google Scholar]
  • 5.Helbig, J. H., S. Bernander, M. Castellani Pastoris, J. Etienne, V. Gaia, S. Lauwers, D. Lindsay, P. C. Luck, T. Marques, S. Mentula, M. F. Peeters, C. Pelaz, M. Struelens, S. A. Uldum, G. Wewalka, and T. G. Harrison. 2002. Pan-European study on culture-proven legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur. J. Clin. Microbiol. Infect. Dis. 21:710-716. [DOI] [PubMed] [Google Scholar]
  • 6.International Organization for Standardization. 1998. ISO 11731:1998. Water quality—detection and enumeration of Legionella. International Organization for Standardization, Geneva, Switzerland.
  • 7.Lee, T. C., J. E. Stout, and V. L. Yu. 1988. Factors predisposing to Legionella pneumophila colonization in residential water systems. Arch. Environ. Health. 43:59-62. [DOI] [PubMed] [Google Scholar]
  • 8.Lo Presti, F., S. Riffard, F. Vandenesch, and J. Etienne. 1998. Identification of Legionella species by random amplified polymorphic DNA profiles. J. Clin. Microbiol. 36:3193-3197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Martinelli, F., A. Caruso, L. Moschini, A. Turano, C. Scarcella, and F. Speziani. 2000. A comparison of Legionella pneumophila occurrence in hot water tanks and instantaneous devices in domestic, nosocomial, and community environments. Curr. Microbiol. 41:374-376. [DOI] [PubMed] [Google Scholar]
  • 10.Muder, R. R., and V. L. Yu. 2002. Infection due to Legionella species other than L. pneumophila. Clin. Infect. Dis. 35:990-998. [DOI] [PubMed] [Google Scholar]
  • 11.Rangel-Frausto, M. S., P. Rhomberg, R. J. Hollis, M. A. Pfaller, R. P. Wenzel, C. M. Helms, and L. A. Herwaldt. 1999. Persistence of Legionella pneumophila in a hospital's water system: a 13-year survey. Infect. Control Hosp. Epidemiol. 20:793-797. [DOI] [PubMed] [Google Scholar]
  • 12.Ratcliff, R. M., J. A. Lanser, P. A. Manning, and M. W. Heuzenroeder. 1998. Sequence-based classification scheme for the genus Legionella targeting the mip gene. J. Clin. Microbiol. 36:1560-1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Steinert, M., U. Hentschel, and J. Hacker. 2002. Legionella pneumophila: an aquatic microbe goes astray. FEMS Microbiol. Rev. 26:149-162. [DOI] [PubMed] [Google Scholar]
  • 14.Stout, J. E., V. L. Yu, Y. C. Yee, S. Vaccarello, W. Diven, and T. C. Lee. 1992. Legionella pneumophila in residential water supplies: environmental surveillance with clinical assessment for Legionnaires' disease. Epidemiol. Infect. 109:49-57. [PMC free article] [PubMed] [Google Scholar]
  • 15.Vickers, R. M., V. L. Yu, S. S. Hanna, P. Muraca, W. Diven, N. Carmen, and F. B. Taylor. 1987. Determinants of Legionella pneumophila contamination of water distribution systems: 15-hospital prospective study. Infect. Control 8:357-363. [DOI] [PubMed] [Google Scholar]
  • 16.Yu, V. L., J. F. Plouffe, M. C. Pastoris, J. E. Stout, M. Schousboe, A. Widmer, J. Summerserogroupill, T. File, C. M. Heath, D. L. Paterson, and A. Chereshsky. 2002. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J. Infect. Dis. 186:127-128. [DOI] [PubMed] [Google Scholar]
  • 17.Zietz, B., J. Wiese, F. Brengelmann, and H. Dunkelberg. 2001. Presence of Legionellaceae in warm water supplies and typing of strains by polymerase chain reaction. Epidemiol. Infect. 126:147-152. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES